Affiliations 

  • 1 Family Medicine, Universiti Putra Malaysia Fakulti Perubatan dan Sains Kesihatan, Serdang, Malaysia
  • 2 Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
  • 3 Primary and Intermediate Care Section, King's College London, London, UK
  • 4 Biostatistics and Health Informatics, Institute of Psychiatry, King's College London, London, UK
  • 5 Women and Children's Health, Faculty of Life Sciences and Medicine, King's College London, London, UK
  • 6 Research Center for Optimal Health, University of Westminster, London, UK
  • 7 Nutrition and Dietetics, University Putra Malaysia, Serdang, Malaysia
  • 8 Obstetrics and Gynaecology, Universiti Putra Malaysia Fakulti Perubatan dan Sains Kesihatan, Serdang, Malaysia
  • 9 Rehabilitation, Universiti Putra Malaysia, Serdang, Malaysia
  • 10 Family Medicine, Universiti Putra Malaysia Fakulti Perubatan dan Sains Kesihatan, Serdang, Malaysia chewboonhow@upm.edu.my
  • 11 Institute of Psychiatry, King's College London, London, UK
BMJ Open, 2021 08 26;11(8):e044878.
PMID: 34446477 DOI: 10.1136/bmjopen-2020-044878

Abstract

INTRODUCTION: Women who develop gestational diabetes mellitus (GDM) have an increased risk of developing type 2 diabetes, and to reduce this risk the women have to adopt healthy behaviour changes. Although previous studies have explored the challenges and facilitators to initiate behaviour change among women with GDM, there is limited data from Malaysian women. Thus, this study will explore the factors affecting the uptake of healthy behaviour changes and the use of digital technology among women and their healthcare providers (HCPs) to support healthy behaviour changes in women with GDM.

METHODS AND ANALYSIS: The study will be modelled according to the Capability, Opportunity, Motivation and Behaviour and Behaviour Change Wheel techniques, and use the DoTTI framework to identify needs, solutions and testing of a preliminary mobile app, respectively. In phase 1 (design and development), a focus group discussion (FGDs) of 5-8 individuals will be conducted with an estimated 60 women with GDM and 40 HCPs (doctors, dietitians and nurses). Synthesised data from the FGDs will then be combined with content from an expert committee to inform the development of the mobile app. In phase 2 (testing of early iterations), a preview of the mobile app will undergo alpha testing among the team members and the app developers, and beta testing among 30 women with GDM or with a history of GDM, and 15 HCPs using semi-structured interviews. The outcome will enable us to optimise an intervention using the mobile app as a diabetes prevention intervention which will then be evaluated in a randomised controlled trial.

ETHICS AND DISSEMINATION: The project has been approved by the Malaysia Research Ethics Committee. Informed consent will be obtained from all participants. Outcomes will be presented at both local and international conferences and submitted for publications in peer-reviewed journals.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications